119 related articles for article (PubMed ID: 16802828)
1. Optimization of bivalent glutathione S-transferase inhibitors by combinatorial linker design.
Mahajan SS; Hou L; Doneanu C; Paranji R; Maeda D; Zebala J; Atkins WM
J Am Chem Soc; 2006 Jul; 128(26):8615-25. PubMed ID: 16802828
[TBL] [Abstract][Full Text] [Related]
2. Discovery of glutathione S-transferase inhibitors using dynamic combinatorial chemistry.
Shi B; Stevenson R; Campopiano DJ; Greaney MF
J Am Chem Soc; 2006 Jul; 128(26):8459-67. PubMed ID: 16802811
[TBL] [Abstract][Full Text] [Related]
3. Bivalent inhibitors of glutathione S-transferase: the effect of spacer length on isozyme selectivity.
Maeda DY; Mahajan SS; Atkins WM; Zebala JA
Bioorg Med Chem Lett; 2006 Jul; 16(14):3780-3. PubMed ID: 16675217
[TBL] [Abstract][Full Text] [Related]
4. Novel class of bivalent glutathione S-transferase inhibitors.
Lyon RP; Hill JJ; Atkins WM
Biochemistry; 2003 Sep; 42(35):10418-28. PubMed ID: 12950168
[TBL] [Abstract][Full Text] [Related]
5. 1.3-A resolution structure of human glutathione S-transferase with S-hexyl glutathione bound reveals possible extended ligandin binding site.
Le Trong I; Stenkamp RE; Ibarra C; Atkins WM; Adman ET
Proteins; 2002 Sep; 48(4):618-27. PubMed ID: 12211029
[TBL] [Abstract][Full Text] [Related]
6. Assembly of ligands interaction models for glutathione-S-transferases from Plasmodium falciparum, human and mouse using enzyme kinetics and molecular docking.
Al-Qattan MN; Mordi MN; Mansor SM
Comput Biol Chem; 2016 Oct; 64():237-249. PubMed ID: 27475235
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional structure of glutathione S-transferase from Arabidopsis thaliana at 2.2 A resolution: structural characterization of herbicide-conjugating plant glutathione S-transferases and a novel active site architecture.
Reinemer P; Prade L; Hof P; Neuefeind T; Huber R; Zettl R; Palme K; Schell J; Koelln I; Bartunik HD; Bieseler B
J Mol Biol; 1996 Jan; 255(2):289-309. PubMed ID: 8551521
[TBL] [Abstract][Full Text] [Related]
8. Characterization of bromosulphophthalein binding to human glutathione S-transferase A1-1: thermodynamics and inhibition kinetics.
Kolobe D; Sayed Y; Dirr HW
Biochem J; 2004 Sep; 382(Pt 2):703-9. PubMed ID: 15147239
[TBL] [Abstract][Full Text] [Related]
9. Human cytosolic glutathione transferases: structure, function, and drug discovery.
Wu B; Dong D
Trends Pharmacol Sci; 2012 Dec; 33(12):656-68. PubMed ID: 23121834
[TBL] [Abstract][Full Text] [Related]
10. The glutathione conjugate of ethacrynic acid can bind to human pi class glutathione transferase P1-1 in two different modes.
Oakley AJ; Lo Bello M; Mazzetti AP; Federici G; Parker MW
FEBS Lett; 1997 Dec; 419(1):32-6. PubMed ID: 9426214
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of 2-substituted-5-(4-nitrophenylsulfonamido)benzoxazoles as human GST P1-1 inhibitors, and description of the binding site features.
Ertan-Bolelli T; Musdal Y; Bolelli K; Yilmaz S; Aksoy Y; Yildiz I; Aki-Yalcin E; Yalcin I
ChemMedChem; 2014 May; 9(5):984-92. PubMed ID: 24677708
[TBL] [Abstract][Full Text] [Related]
12. Potent isozyme-selective inhibition of human glutathione S-transferase A1-1 by a novel glutathione S-conjugate.
Cacciatore I; Caccuri AM; Cocco A; De Maria F; Di Stefano A; Luisi G; Pinnen F; Ricci G; Sozio P; Turella P
Amino Acids; 2005 Nov; 29(3):255-61. PubMed ID: 16082503
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibitors of glutathione transferase P1 with trioxane structure as anticancer agents.
Bräutigam M; Teusch N; Schenk T; Sheikh M; Aricioglu RZ; Borowski SH; Neudörfl JM; Baumann U; Griesbeck AG; Pietsch M
ChemMedChem; 2015 Apr; 10(4):629-39. PubMed ID: 25694385
[TBL] [Abstract][Full Text] [Related]
14. Exploration of in vitro pro-drug activation and futile cycling by glutathione S-transferases: thiol ester hydrolysis and inhibitor maturation.
Ibarra C; Grillo MP; Lo Bello M; Nucettelli M; Bammler TK; Atkins WM
Arch Biochem Biophys; 2003 Jun; 414(2):303-11. PubMed ID: 12781783
[TBL] [Abstract][Full Text] [Related]
15. Organometallic ruthenium inhibitors of glutathione-S-transferase P1-1 as anticancer drugs.
Ang WH; De Luca A; Chapuis-Bernasconi C; Juillerat-Jeanneret L; Lo Bello M; Dyson PJ
ChemMedChem; 2007 Dec; 2(12):1799-806. PubMed ID: 17918761
[TBL] [Abstract][Full Text] [Related]
16. A novel antioxidant role for ligandin behavior of glutathione S-transferases: attenuation of the photodynamic effects of hypericin.
Lu WD; Atkins WM
Biochemistry; 2004 Oct; 43(40):12761-9. PubMed ID: 15461448
[TBL] [Abstract][Full Text] [Related]
17. Design and structure-activity relationship of thrombin inhibitors with an azaphenylalanine scaffold: potency and selectivity enhancements via P2 optimization.
Zega A; Mlinsek G; Sepic P; Golic Grdadolnik S; Solmajer T; Tschopp TB; Steiner B; Kikelj D; Urleb U
Bioorg Med Chem; 2001 Oct; 9(10):2745-56. PubMed ID: 11557360
[TBL] [Abstract][Full Text] [Related]
18. Bivalent enzyme inhibitors discovered using dynamic covalent chemistry.
Clipson AJ; Bhat VT; McNae I; Caniard AM; Campopiano DJ; Greaney MF
Chemistry; 2012 Aug; 18(34):10562-70. PubMed ID: 22782854
[TBL] [Abstract][Full Text] [Related]
19. Stereoselective conjugation of prostaglandin A2 and prostaglandin J2 with glutathione, catalyzed by the human glutathione S-transferases A1-1, A2-2, M1a-1a, and P1-1.
Bogaards JJ; Venekamp JC; van Bladeren PJ
Chem Res Toxicol; 1997 Mar; 10(3):310-7. PubMed ID: 9084911
[TBL] [Abstract][Full Text] [Related]
20. Design of potent inhibitors for Schistosoma japonica glutathione S-transferase.
Jao SC; Chen J; Yang K; Li WS
Bioorg Med Chem; 2006 Jan; 14(2):304-18. PubMed ID: 16275109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
